GENTHERAPIE
European patent · EP3262066 · In force
Register entry
- Publication number
- EP3262066
- Application number
- EP16788764
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Maintained in amended form
- Filed
- Oct 27, 2016
- Published
- Jan 3, 2018
- Granted
- Feb 7, 2018
- Protection ends at the latest
- Oct 26, 2036
- Next annual fee due
- Oct 31, 2026
- IPC classes
- C07K 14/47 (2006.01)C12N 9/64 (2006.01)
- Priority
- GB 201519086 28.10.2015
- PCT application
- PCT/GB2016/053343 27.10.2016
- PCT publication
- WO2017/072515 04.05.2017
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Nov 1, 2025
Change
Published in Swissreg on 01.11.2025
- Nov 1, 2024
Change
Published in Swissreg on 01.11.2024
- Jan 26, 2024
Change
Published in Swissreg on 26.01.2024
- May 10, 2023
Change
Published in Swissreg on 10.05.2023
- Nov 16, 2022
Change
Published in Swissreg on 16.11.2022
- Sep 22, 2021
Change
Published in Swissreg on 22.09.2021
- Sep 22, 2021
Change
Published in Swissreg on 22.09.2021
- Sep 1, 2021
Transferred
- Owner
- Syncona Investment Management Limited, 215 Euston Road, London NW1 2BE, United Kingdom → Syncona IP Holdco Limited, 8 Bloomsbury Street, London WC1B 3SR, United Kingdom
Published in Swissreg on 01.09.2021
1 earlier entry
- Feb 7, 2018
Granted
Published in Swissreg on 07.02.2018
Parties
Inventor
Cambridge Cambridgeshire CB2 8BZ, GB
London NW1 2BE, GB
London NW1 2BE, GB
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.